The effects of the dietary supplement Cardioflex Q10 on reducing cardiovascular disease risk factors in adults

Simple item page
dc.contributor.authorKouritzin, Trevor
dc.contributor.examiningcommitteeMollard, Rebecca (Food and Human Nutritional Sciences)en_US
dc.contributor.examiningcommitteeSuh, Miyoung (Food and Human Nutritional Sciences)en_US
dc.contributor.examiningcommitteeCornish, Stephen (Kinesiology and Recreation Management)en_US
dc.contributor.supervisorMyrie, Semone (Food and Human Nutritional Sciences)en_US
dc.date.accessioned2020-09-18T21:25:16Z
dc.date.available2020-09-18T21:25:16Z
dc.date.copyright2020-09-17
dc.date.issued2020en_US
dc.date.submitted2020-08-27T21:53:11Zen_US
dc.date.submitted2020-09-18T02:43:54Zen_US
dc.degree.disciplineFood and Human Nutritional Sciencesen_US
dc.degree.levelMaster of Science (M.Sc.)en_US
dc.description.abstractThe objective of this study was to determine whether daily supplementation with the multi-ingredient dietary supplement Cardioflex for 90 days would improve cardiovascular disease risk factors in adults aged 30 – 65 years old. A randomized double-blind placebo-controlled parallel clinical study was conducted with 67 participants who received one daily serving (10g) of Cardioflex (n=33) or 10g of an isocaloric maltodextrin placebo (n=34). Plasma lipid profile, anthropometric measures, cardiac measures, inflammatory and endothelial function biomarkers were measured at baseline and endpoint of the study. Analysis of covariance was conducted using SPSS. In this study, heart rate variability (HRV) increased for the Cardioflex group (65.24 ± 9.44 ms to 68.72 ± 9.78 ms) while a decrease (69.95 ± 9.37 ms to 63.68 ± 9.08 ms) was seen in the placebo group, resulting in an overall 6.8 millisecond higher post-treatment HRV in the Cardioflex group (P=0.04). There were no other significant time x group interactions from the Cardioflex treatment. Further research is needed to explore Cardioflex’s potential effects on HRV and other cardiovascular disease risk factors.en_US
dc.description.noteOctober 2020en_US
dc.identifier.urihttp://hdl.handle.net/1993/35079
dc.language.isoengen_US
dc.rightsopen accessen_US
dc.subjectCardiovascularen_US
dc.subjectSupplementsen_US
dc.subjectCardiovascular diseaseen_US
dc.titleThe effects of the dietary supplement Cardioflex Q10 on reducing cardiovascular disease risk factors in adultsen_US
dc.typemaster thesisen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Kouritzin_Trevor.pdf
Size:
1.24 MB
Format:
Adobe Portable Document Format
Description:
Thesis
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
2.2 KB
Format:
Item-specific license agreed to upon submission
Description:
Download
Collections
FGS - Electronic Theses and Practica